期刊文献+

新型去甲万古霉素-纤维蛋白胶磷酸钙缓释系统中抗菌素的体外释放规律 被引量:3

The releasing raw of the antibiotic in vitro in a new norvancomycin-fibrin glue calcium phosphate bone substitute
下载PDF
导出
摘要 目的:通过对比两种磷酸钙人工骨中去甲万古霉素在体外的释放规律,为新型载药缓释系统的临床应用提供实验依据。方法:将适量去甲万古霉素粉末以生理盐水充分溶解,制成一定浓度抗菌素溶液,逐步稀释形成去甲万古霉素标准液的浓度梯度,在一定温度下,以紫外分光光度计在200-800 nm波段间进行连续扫描,取最大吸收峰值处波长为以后测量的参考波长,将各浓度下测得的光密度(optical density下称OD值)导入SPSS13.0软件包中,计算溶液标准回归方程并检验之。分别将一定量新制备的两组材料试件投于生理盐水中持续浸提,定期更换试管取浸提液,在上述参考波长下测其光密度,代入方程计算各期浸提液中去甲万古霉素的浓度及累计释放量。结果:去甲万古霉素溶液在25℃条件下于226 nm波长处出现最高峰,OD值随浓度x(mg·L-1)的标准回归方程为:OD=0.013x+0.173(R2=0.971,调整R2=0.964,方程检验P=0.00),实验组维持有效浓度可达6周以上,较对照组明显延长。结论:纤维蛋白胶可明显延长载药缓释体系中抗生素的释放时间,早期遵循Higuchi's规律。 Objective: By comparing of the release law of norvancomycin in two calcium phosphate bone substitute in vitro, we aim to provide experimental evidence for clinical application of the new-type drug delivery system. Methods: Norvancomycin powder was fully dissolved in saline to make a certain concentration, and gradually diluted to form a gradient of norvancomycin. UV spectrophotometer was applied to successively scan at 200 - 800 nm bands at a certain temperature, and the wavelength of maximum absorption peak was considered as the reference wavelength, every concentrations measured were absorhanced into SPSS13.0 package, calculated and tested the regression equation of the standard solution. Respectively, a certain amount of the two new-made material was put into saline and extracted continously, regular changed the tube to take extracts,measured its optical density( OD value) at the reference wavelength absorhance above, and all OD values in each period were substituted into the equation and concentrations of norvancomycin and the total emissions were calculated. Results : Under room condition of 25 ℃, standard NV solution had a maximum absorption peak at a wavelength of 226 nm. The relationship between OD value and concentration x (mg · L^-1) of the standard NV solution can be described as : OD = 0. 013x + 0. 173 ( R2 = 0. 971, adjusting R2 = 0. 964,P = 0.00). In Experimental Group an effective concentration could last for 6 weeks, significantly longer than that in the Control Group. Conclusions: Fibrin glue can significantly prolong the drug release system for antibiotic release time, and follow the law of Higuchi's in early period.
出处 《赣南医学院学报》 2014年第1期25-27,42,共4页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 磷酸钙 纤维蛋白胶 去甲万古霉素 生物材料 释放规律 calcium phosphate fibrin glue norvancomycin biological materials release law
  • 相关文献

参考文献7

  • 1张飞,李奇,林荔军,叶建东,刘成龙,刘登均,赵亮.新型去甲万古霉素-纤维蛋白胶磷酸钙人工骨研究[J].广东医学,2010,31(6):688-690. 被引量:6
  • 2张飞,李奇,林荔军,高辉,王鹏程.去甲万古霉素-纤维蛋白胶磷酸钙人工骨的急性细胞毒性、抗溃散性和抗冲涮性研究[J].广东医学,2012,33(7):898-901. 被引量:2
  • 3Habraken WJ, Wolke JG, Mikos AG, et al. PLGA micro- sphere/calciumphosphate cement composites for tissue en- gineering: in vitro release and degradation characteristics [J]. J Biomater Sci Polym Ed,2008, 19 (9) : 1171 - 1188.
  • 4Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: a review [ J ]. J Control Release, 2006,113 ( 2 ) : 102 - 110.
  • 5M. Takechi, Y. Miyamoto, K. Ishikawa, et al. Effects of added antibiotics on the basic properties of anti-washout -type ast-setting calcium phosphate cement [ J ]. J Bi- omed Mater Res,1998,39 (2) :308 -316.
  • 6T. Higuchi, Mechanism of sustained-action medication. Theoretical analysis of release of solid drugs dispersed in solid matrices [ J ]. J Pharm Sci, 1963,52 : 1143 - 1149.
  • 7Le, N. D. , Saffarzadeh A, Aguado E, et al. Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites[J]. J Mater Sci Mater Med, 2007, 18 (2) :225 - 235.

二级参考文献22

  • 1YAZAR S,LIN C H,WEI F C.One-stage reconstruction of composite bone and soft-tissue defects in traumatic lower extremities[J].Plast Reconstr Surg,2004,114(6):1457-1466.
  • 2AMBARD A J,MUENINGHOFf L.Calcium phosphate cement:review of mechanical and biological properties[J].J Prosthodont,2006,15(5):321-328.
  • 3GINEBRA M P,TRAYKOVA T,PLANELL J A.Calcium phosphate cements as bone drug delivery systems:a review[J].J Control Release,2006,113(2):102-110.
  • 4LEE R W,VOLZ R G,SHERIDAN D C.The role of fixation and bone quality on the mechanical stability of tibial knee components[J].Clin Orthop Relat Res,1991(273):177-183.
  • 5KAFKOV(A) B,BOS(A) KOV(A) Z,TES(A)ROV(A) E,et al.Vancomycin as chiral selector for enantioselective separation of selected profen nonsteroidal anti-inflammatory drugs in capillary liquid chromatography[J].Chirality,2006,18(7):531-538.
  • 6HAERDI LANDERER M C,HABERMACHER J,WENGER B,et al.Slow release antibiotics for treatment of septic arthritis in large animals[J].Vet J,2010,184(1):14-20.
  • 7BAROUD G,SWANSON T,STEFFEN T.Setting properties of four acrylic and two calcium-phosphate cements used in vertebroplasty[J].J Long Term Eff Med Implants,2006,16(1):51-59.
  • 8SASAKI T,ISHIBASHI Y,KATANO H,et al.In vitro elution of vancomycin from calcium phosphate cement[J].J Arthroplasty,2005,20(8):1055-1059.
  • 9LE N D,SAFFARZADEH A,AGUADO E,et al.Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites[J].J Mater Sci Mater Med,2007,18(2):225-235.
  • 10KHAIROUN I,BOLTONG M G,DRIES SENS F C,et al.Effect of calcium carbonate on the compliance of an apatitic calcium phosphate bone cement[J].Biomaterials,1997,18(23):1535-1539.

共引文献5

同被引文献35

  • 1王茂源,赵建宁,吴苏稼,包倪荣.万古霉素磷钙骨水泥在人工髋关节置换术后感染二期翻修术中作用的实验研究[J].中国矫形外科杂志,2006,14(6):443-445. 被引量:12
  • 2Kaczmarczyk J,Sowinski P,Goch M,et al.Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors:aprospective pilot study[J].BMC Musculoskelet Disord,2015(16):369.
  • 3Morris BJ,Richards JE,Guillamondegui OD,et al.Obesity increases early complications after high-energy pelvic and acetabular fractures[J].Orthopedics,2015,38(10):e881-887.
  • 4Rand BC,Penn-Barwell JG,Wenke JC.Combined local and systemic antibiotic delivery improves eradication of wound contamination:an animal experimental model of contaminated fracture[J].Bone Joint J,2015,97-B(10):1423-1427.
  • 5Matos AC,Marques CF,Pinto RV,et al.Novel doped calcium phosphate-PMMA bone cement composites as levofloxacin delivery systems[J].Int J Pharm,2015,490(1-2):200-208.
  • 6Uskokovic V.Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis[J].Crit Rev Ther Drug Carrier Syst,2015,32(1):1-59.
  • 7Ordikhani F,Dehghani M,Simchi A.Antibiotic-loaded chitosan-Laponite films for local drug delivery by titanium implants:cell proliferation and drug release studies[J].J Mater Sci Mater Med,2015,26(12):269.
  • 8Kanakaris N,Gudipati S,Tosounidis T,et al.The treatment of intramedullary osteomyelitis of the femur and tibia using the Reamer-Irrigator-Aspirator system and antibiotic cement rods[J].Bone Joint J,2014,96-B(6):783-788.
  • 9Doty HA,Leedy MR,Courtney HS,et al.Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin andrecombinant human bone morphogenetic protein-2[J].J Mater Sci Mater Med,2014,25(6):1449-1459.
  • 10Huang JG,Pang L,Chen ZR,et al.Dual-delivery of vancomycin and icariin from an injectable calcium phosphate cementrelease system for controlling infection and improving bone healing[J].Mol Med Rep,2013,8(4):1221-1227.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部